Lanean...
Thrombosis centres and AVKs monitoring in COVID-19 pandemic
Vitamin K-Antagonists (VKAs) are the treatment of choice in patients with indications other than atrial fibrillation and venous thromboembolism. Moreover, some patients still assume VKAs refusing to change their therapy when direct oral anticoagulants (DOACs) are properly indicated. The COVID-19 pan...
Gorde:
| Argitaratua izan da: | Intern Emerg Med |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer International Publishing
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369471/ https://ncbi.nlm.nih.gov/pubmed/32686059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11739-020-02439-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|